Clinical Trial: Peppermint and Decongestant Technique on Chronic Sinusitis

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866937) titled 'Peppermint and Decongestant Technique on Chronic Sinusitis' on Oct. 05.

Brief Summary: Chronic rhinosinusitis (CRS) is defined as persistent symptomatic inflammation of the nasal and sinus mucosa that lasts more than 3 months. Epidemiologic studies estimate that 10% to 15% of the US population has CRS with a prevalence of up to 12% in Western populations. CRS is defined as the symptomatic inflammation of the nose and para nasals in uses with the distinction based on the duration of the complaints. CRS is typically described more broadly as an inflammatory disorder and the importance of specific microbial agents in driving the process...